02.06.2015 16:47:00

Arkema Annual General Shareholder Meeting 2 June 2015

Regulatory News:

Arkema’s (Paris:AKE) shareholders, who represented 62.5 % of the shares carrying votes, adopted all the resolutions submitted to the annual general meeting held today, in particular:

  • Approval of the 2014 Company’s and consolidated financial statements
  • €1.85 dividend per share with option for payment in shares
  • Composition of the Board: approval of renewal of terms of office and appointment

The annual general meeting approved the 2014 Company’s and consolidated financial statements and the distribution of a €1.85 dividend per share.

The meeting also decided that shareholders would be able to opt for the payment of the entire distributed dividend either in cash or in new Arkema shares. Shares will be traded ex-dividend as of 12 June 2015, with either payment of the dividend in cash or delivery of the shares upon exercise of the option taking place from 8 July 2015.

Furthermore, the shareholders approved the appointment of Mrs Hélène Moreau-Leroy, CEO of Hispano-Suiza (Safran Group) as a new director of the Company for a four-year term, who also becomes a member of the Audit and Accounts Committee. The shareholders also renewed all the proposed directors’ terms of office. At the close of the meeting, the new Board comprises twelve directors, including four women.

Finally, at this annual general meeting, Thierry Le Hénaff, Chairman and Chief Executive Officer, and Thierry Lemonnier, Chief Financial Officer, presented Arkema’s highlights and financial performance in 2014. In particular they detailed three recently finalized major projects that will support the Group’s future growth: the acquisition of Bostik, the world’s n° 3 in adhesives, the start-up of the Thiochemicals platform in Malaysia, and the acquisition of a stake in Sunke in acrylics in China. Thierry Le Hénaff and the Chairmen of the Board of Directors committees then respectively presented the activity of the Board and its developments, the work of the Nominating, Compensation and Corporate Governance Committee and the work of the Audit and Accounts Committee.

The full voting results for the resolutions will be available in the coming days on Arkema’s website www.finance.arkema.com under the Annual General Meeting heading.

A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in close to 50 countries, some 19,000 employees and research centers in North America, France and Asia, Arkema generates pro forma annual revenue of some €7.5 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.

Analysen zu ArkemaAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ArkemaAct. 74,15 -1,20% ArkemaAct.